Source: Health Products Regulatory Authority (IE) Revision Year: 2015 Publisher: Phoenix Labs, Suite 12, Bunkilla Plaza, Bracetown Business Park, Clonee, Co. Meath
Etoflam 5% w/w Gel.
| Pharmaceutical Form |
|---|
|
Gel. A nearly transparent yellowish gel. |
The gel contains 5% w/w etofenamate.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Etofenamate |
Etofenamate is a flufenamic acid derivative, which is readily transported through the skin and concentrated in inflamed tissue, where it exerts anti-inflammatory and analgesic effects by inhibiting the release of histamine, lysosomal enzymes and prostaglandin. |
| List of Excipients |
|---|
|
Fatty alcohol polyglycol ether |
Collapsible aluminium tube with an internal coating with polyethylene screw cap. Tubes contain either 20g or 100g of gel product.
Not all pack sizes may be marketed.
Phoenix Labs, Suite 12, Bunkilla Plaza, Bracetown Business Park, Clonee, Co. Meath
PA1113/002/001
Date of first authorisation: 04 April 1990
Date of last renewal: 04 February 2010
| Drug | Countries | |
|---|---|---|
| ETOFLAM | Ireland |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
